|
| 36621880 | Returning integrated genomic risk and clinical recommendations: The eMERGE study. | Genet Med | 2023 |
| 37790445 | Genetic Sex Validation for Sample Tracking in Clinical Testing. | Res Sq | 2023 |
| 37883979 | Prospective, multi-site study of healthcare utilization after actionable monogenic findings from clinical sequencing. | Am J Hum Genet | 2023 |
| 37347242 | ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2023 |
| 34380996 | Genetic association of primary nonresponse to anti-TNFα therapy in patients with inflammatory bowel disease. | Pharmacogenet Genomics | 2022 |
| 35802134 | ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2022 |
| 36721401 | Anti-racist strategies for clinical and translational research: Design, implementation, and lessons learned from a new course. | J Clin Transl Sci | 2022 |
| 36372681 | Quantifying the phenome-wide disease burden of obesity using electronic health records and genomics. | Obesity (Silver Spring) | 2022 |
| 35915156 | Large-scale genome-wide association study of coronary artery disease in genetically diverse populations. | Nat Med | 2022 |
| 35216901 | The reckoning: The return of genomic results to 1444 participants across the eMERGE3 Network. | Genet Med | 2022 |
| 34906521 | Response to McGurk et al. | Genet Med | 2022 |
| 34930020 | Arrhythmia Variant Associations and Reclassifications in the eMERGE-III Sequencing Study. | Circulation | 2022 |
| 35322684 | Practitioners' Confidence and Desires for Education in Cardiovascular and Sudden Cardiac Death Genetics. | J Am Heart Assoc | 2022 |
| 32964493 | Loci identified by a genome-wide association study of carotid artery stenosis in the eMERGE network. | Genet Epidemiol | 2021 |
| 33850243 | Medical records-based chronic kidney disease phenotype for clinical care and "big data" observational and genetic studies. | NPJ Digit Med | 2021 |
| 33848333 | Multiplexing mutation rate assessment: determining pathogenicity of Msh2 variants in Saccharomyces cerevisiae. | Genetics | 2021 |
| 34377931 | Penetrance of Breast Cancer Susceptibility Genes From the eMERGE III Network. | JNCI Cancer Spectr | 2021 |
| 34302027 | Quantitative disease risk scores from EHR with applications to clinical risk stratification and genetic studies. | NPJ Digit Med | 2021 |
| 34345026 | Correction to: ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2021 |
| 34151428 | Genome-Wide Approach to Measure Variant-Based Heritability of Drug Outcome Phenotypes. | Clin Pharmacol Ther | 2021 |
| 34012069 | Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2021 |
| 34012068 | ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2021 |
| 33977795 | Pleiotropy of systemic lupus erythematosus risk alleles and cardiometabolic disorders: A phenome-wide association study and inverse-variance weighted meta-analysis. | Lupus | 2021 |
| 33951936 | Practice Patterns After Return of Rare Variants Associated With Cardiomyopathy in the Electronic Medical Records and Genomics Network. | Circ Heart Fail | 2021 |
| 33407432 | Association between triglycerides, known risk SNVs and conserved rare variation in SLC25A40 in a multi-ancestry cohort. | BMC Med Genomics | 2021 |
| 32307929 | Pleiotropy in the Genetic Predisposition to Rheumatoid Arthritis: A Phenome-Wide Association Study and Inverse Variance-Weighted Meta-Analysis. | Arthritis Rheumatol | 2020 |
| 35047832 | Hemochromatosis risk genotype is not associated with colorectal cancer or age at its diagnosis. | HGG Adv | 2020 |
| 30298529 | The eMERGE genotype set of 83,717 subjects imputed to ~40â¿¿million variants genome wide and association with the herpes zoster medical record phenotype. | Genet Epidemiol | 2019 |
| 31422818 | Rates of Actionable Genetic Findings in Individuals with Colorectal Cancer or Polyps Ascertained from a Community Medical Setting. | Am J Hum Genet | 2019 |
| 30988330 | Heritability and genome-wide association study of benign prostatic hyperplasia (BPH) in the eMERGE network. | Sci Rep | 2019 |
| 30166544 | A study paradigm integrating prospective epidemiologic cohorts and electronic health records to identify disease biomarkers. | Nat Commun | 2018 |
| 28502727 | Concordance between Research Sequencing and Clinical Pharmacogenetic Genotyping in the eMERGE-PGx Study. | J Mol Diagn | 2017 |
| 26736087 | PGRNseq: a targeted capture sequencing panel for pharmacogenetic research and implementation. | Pharmacogenet Genomics | 2016 |
| 28361098 | Building a family network from genetic testing. | Mol Genet Genomic Med | 2016 |
| 26746457 | Association of Arrhythmia-Related Genetic Variants With Phenotypes Documented in Electronic Medical Records. | JAMA | 2016 |
| 26857349 | Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network. | Clin Pharmacol Ther | 2016 |
| 25946405 | Variation in genes controlling warfarin disposition and response in American Indian and Alaska Native people: CYP2C9, VKORC1, CYP4F2, CYP4F11, GGCX. | Pharmacogenet Genomics | 2015 |
| 26221186 | Prospective participant selection and ranking to maximize actionable pharmacogenetic variants and discovery in the eMERGE Network. | Genome Med | 2015 |
| 24282029 | Quantifying rare, deleterious variation in 12 human cytochrome P450 drug-metabolism genes in a large-scale exome dataset. | Hum Mol Genet | 2014 |
| 25087612 | Pathogenic variants for Mendelian and complex traits in exomes of 6,517 European and African Americans: implications for the return of incidental results. | Am J Hum Genet | 2014 |
| 24960519 | Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems. | Clin Pharmacol Ther | 2014 |
| 24616401 | Refining the structure and content of clinical genomic reports. | Am J Med Genet C Semin Med Genet | 2014 |
| 24711634 | Rare coding variation in paraoxonase-1 is associated with ischemic stroke in the NHLBI Exome Sequencing Project. | J Lipid Res | 2014 |
| 23778323 | Pharmacogenetics in American Indian populations: analysis of CYP2D6, CYP3A4, CYP3A5, and CYP2C9 in the Confederated Salish and Kootenai Tribes. | Pharmacogenet Genomics | 2013 |
| 24013571 | Exome sequencing reveals novel rare variants in the ryanodine receptor and calcium channel genes in malignant hyperthermia families. | Anesthesiology | 2013 |
| 18282109 | Adaptations to climate in candidate genes for common metabolic disorders. | PLoS Genet | 2008 |